DUBLIN–(BUSINESS WIRE)–The “Oncology Based in-Vivo CRO – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Oncology Based In-Vivo CRO was estimated at US$1.5 Billion in 2023 and is projected to reach US$2.5 Billion by 2030, growing at a CAGR of 7.0% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Oncology-based In-
Go to Source
Author: